Genmab A/S

General ticker "GNMSF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $14.4B (TTM average)

Genmab A/S follows the US Stock Market performance with the rate: 43.6%.

Estimated limits based on current volatility of 1.4%: low 314.21$, high 322.52$

Factors to consider:

  • Total employees count: 548 as of 2019
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [246.01$, 376.55$]
  • 2024-12-30 to 2025-12-30 estimated range: [238.52$, 367.19$]

Financial Metrics affecting the GNMSF estimates:

  • Negative: with PPE of 26.5 at the end of fiscal year the price was very high
  • Positive: Operating profit margin, % of 32.30 > 18.64
  • Positive: Return on assets ratio (scaled to [-100,100]) of 13.77 > 6.04
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 89.57 > 63.39
  • Negative: Industry earnings per price (median), % of -22.08 <= 0
  • Positive: Inventory ratio change, % of 0.37 <= 0.84
  • Positive: 0.33 < Operating cash flow per share per price, % of 5.34

Similar symbols

Short-term GNMSF quotes

Long-term GNMSF plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue DKK8,482.00MM DKK14,595.00MM DKK16,474.00MM
Operating Expenses DKK5,529.00MM DKK8,328.00MM DKK11,153.00MM
Operating Income DKK2,953.00MM DKK6,267.00MM DKK5,321.00MM
Non-Operating Income DKK1,030.00MM DKK678.00MM DKK316.00MM
Interest Expense DKK13.00MM DKK21.00MM DKK27.00MM
R&D Expense DKK4,181.00MM DKK5,562.00MM DKK7,630.00MM
Income(Loss) DKK3,983.00MM DKK6,945.00MM DKK5,637.00MM
Taxes DKK975.00MM DKK1,493.00MM DKK0.00MM
Profit(Loss)* DKK3,008.00MM DKK3,869.00MM DKK4,352.00MM
Stockholders Equity DKK22,196.00MM DKK27,282.00MM DKK31,610.00MM
Inventory DKK0.00MM DKK0.00MM DKK57.00MM
Assets DKK24,627.00MM DKK30,119.00MM DKK35,289.00MM
Operating Cash Flow DKK2,228.00MM DKK3,912.00MM DKK7,380.00MM
Capital expenditure DKK252.00MM DKK317.00MM DKK376.00MM
Investing Cash Flow DKK-961.00MM DKK-2,761.00MM DKK-1,282.00MM
Financing Cash Flow DKK-420.00MM DKK-789.00MM DKK-606.00MM
Earnings Per Share** DKK46.00 DKK59.17 DKK66.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.